These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

702 related items for PubMed ID: 29358056

  • 1. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
    Barrera J, Schutta C, Pisano M, Grubman MJ, Brake DA, Miller T, Kamicker BJ, Olutunmbi F, Ettyreddy D, Brough DE, Butman BT, Neilan JG.
    Vaccine; 2018 Feb 14; 36(8):1078-1084. PubMed ID: 29358056
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model.
    Neilan JG, Schutta C, Barrera J, Pisano M, Zsak L, Hartwig E, Rasmussen MV, Kamicker BJ, Ettyreddy D, Brough DE, Butman BT, Brake DA.
    BMC Vet Res; 2018 Aug 29; 14(1):254. PubMed ID: 30157853
    [Abstract] [Full Text] [Related]

  • 3. Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge.
    Schutta C, Barrera J, Pisano M, Zsak L, Grubman MJ, Mayr GA, Moraes MP, Kamicker BJ, Brake DA, Ettyreddy D, Brough DE, Butman BT, Neilan JG.
    Vaccine; 2016 Jun 08; 34(27):3214-3220. PubMed ID: 26707216
    [Abstract] [Full Text] [Related]

  • 4. Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.
    Barrera J, Brake DA, Schutta C, Ettyreddy D, Kamicker BJ, Rasmussen MV, Bravo de Rueda C, Zurita M, Pisano M, Hurtle W, Brough DE, Butman BT, Harper BG, Neilan JG.
    Vaccine; 2018 Nov 19; 36(48):7345-7352. PubMed ID: 30327212
    [Abstract] [Full Text] [Related]

  • 5. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
    Sitt T, Kenney M, Barrera J, Pandya M, Eckstrom K, Warner M, Pacheco JM, LaRocco M, Palarea-Albaladejo J, Brake D, Rieder E, Arzt J, Barlow JW, Golde WT.
    Vaccine; 2019 Sep 30; 37(42):6221-6231. PubMed ID: 31493951
    [Abstract] [Full Text] [Related]

  • 6. Safety profile of a replication-deficient human adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle.
    Barrera J, Brake DA, Kamicker BJ, Purcell C, Kaptur R, Schieber T, Lechtenberg K, Miller TD, Ettyreddy D, Brough DE, Butman BT, Colby M, Neilan JG.
    Transbound Emerg Dis; 2018 Apr 30; 65(2):447-455. PubMed ID: 29076657
    [Abstract] [Full Text] [Related]

  • 7. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
    Sreenivasa BP, Mohapatra JK, Pauszek SJ, Koster M, Dhanya VC, Tamil Selvan RP, Hosamani M, Saravanan P, Basagoudanavar SH, de Los Santos T, Venkataramanan R, Rodriguez LL, Grubman MJ.
    Vet Microbiol; 2017 May 30; 203():196-201. PubMed ID: 28619144
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle.
    Steigerwald R, Brake DA, Barrera J, Schutta CJ, Kalla M, Wennier ST, Volkmann A, Hurtle W, Clark BA, Zurita M, Pisano M, Kamicker BJ, Puckette MC, Rasmussen MV, Neilan JG.
    Vaccine; 2020 Jan 22; 38(4):769-778. PubMed ID: 31718901
    [Abstract] [Full Text] [Related]

  • 9. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
    Moraes MP, Segundo FD, Dias CC, Pena L, Grubman MJ.
    Vaccine; 2011 Nov 28; 29(51):9431-40. PubMed ID: 22027486
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle.
    Medina GN, Montiel N, Diaz-San Segundo F, Sturza D, Ramirez-Medina E, Grubman MJ, de los Santos T.
    Clin Vaccine Immunol; 2015 Nov 25; 23(2):125-36. PubMed ID: 26607309
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
    Singanallur NB, Pacheco JM, Arzt J, Stenfeldt C, Fosgate GT, Rodriguez L, Vosloo W.
    Antiviral Res; 2017 Sep 25; 145():114-122. PubMed ID: 28780422
    [Abstract] [Full Text] [Related]

  • 12. An adenovirus vectored mucosal adjuvant augments protection of mice immunized intranasally with an adenovirus-vectored foot-and-mouth disease virus subunit vaccine.
    Alejo DM, Moraes MP, Liao X, Dias CC, Tulman ER, Diaz-San Segundo F, Rood D, Grubman MJ, Silbart LK.
    Vaccine; 2013 Apr 26; 31(18):2302-9. PubMed ID: 23499593
    [Abstract] [Full Text] [Related]

  • 13. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ.
    Biologicals; 2005 Dec 26; 33(4):227-34. PubMed ID: 16289996
    [Abstract] [Full Text] [Related]

  • 14. Systemic immune response and virus persistence after foot-and-mouth disease virus infection of naïve cattle and cattle vaccinated with a homologous adenovirus-vectored vaccine.
    Eschbaumer M, Stenfeldt C, Rekant SI, Pacheco JM, Hartwig EJ, Smoliga GR, Kenney MA, Golde WT, Rodriguez LL, Arzt J.
    BMC Vet Res; 2016 Sep 15; 12():205. PubMed ID: 27634113
    [Abstract] [Full Text] [Related]

  • 15. Human adenovirus-vectored foot-and-mouth disease vaccines: establishment of a vaccine product profile through in vitro testing.
    Brake DA, McIlhaney M, Miller T, Christianson K, Keene A, Lohnas G, Purcell C, Neilan J, Schutta C, Barrera J, Burrage T, Brough DE, Butman BT.
    Dev Biol (Basel); 2012 Sep 15; 134():123-33. PubMed ID: 22888605
    [Abstract] [Full Text] [Related]

  • 16. Intra-serotype SAT2 chimeric foot-and-mouth disease vaccine protects cattle against FMDV challenge.
    Maree FF, Nsamba P, Mutowembwa P, Rotherham LS, Esterhuysen J, Scott K.
    Vaccine; 2015 Jun 09; 33(25):2909-16. PubMed ID: 25930116
    [Abstract] [Full Text] [Related]

  • 17. A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs.
    De Vleeschauwer AR, Zhou X, Lefebvre DJ, Garnier A, Watier F, Pignon C, Lacour SA, Zientara S, Bakkali-Kassimi L, De Clercq K, Klonjkowski B.
    Vaccine; 2018 Apr 12; 36(16):2193-2198. PubMed ID: 29544690
    [Abstract] [Full Text] [Related]

  • 18. Early protection against foot-and-mouth disease virus in cattle using an inactivated vaccine formulated with Montanide ESSAI IMS D 12802 VG PR adjuvant.
    Quattrocchi V, Pappalardo JS, Langellotti C, Smitsaart E, Fondevila N, Zamorano P.
    Vaccine; 2014 Apr 17; 32(19):2167-72. PubMed ID: 24631088
    [Abstract] [Full Text] [Related]

  • 19. Recombinant adenovirus co-expressing capsid proteins of two serotypes of foot-and-mouth disease virus (FMDV): in vitro characterization and induction of neutralizing antibodies against FMDV in swine.
    Wu Q, Moraes MP, Grubman MJ.
    Virus Res; 2003 Jun 17; 93(2):211-9. PubMed ID: 12782369
    [Abstract] [Full Text] [Related]

  • 20. Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency.
    Mohana Subramanian B, Madhanmohan M, Sriraman R, Chandrasekhar Reddy RV, Yuvaraj S, Manikumar K, Rajalakshmi S, Nagendrakumar SB, Rana SK, Srinivasan VA.
    Antiviral Res; 2012 Dec 17; 96(3):288-95. PubMed ID: 23043941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.